Empirical Financial Services, LLC d.b.a. Empirical Wealth Management
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1510434
Seattle, WA
Position in TAK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$695,878
-$154,967 QoQ
Shares Held
43,411
-5.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#119
of 376 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $6,468,528 across 13 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
32,067 | $1,680,149 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
43,411 | $695,878 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
19,507 | $676,307 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
24,413 | $619,357 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
18,674 | $586,363 | |
| 6 | HLN |
Haleon plc
|
60,240 | $562,038 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
41,730 | $417,300 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
10,773 | $265,123 |
All Filings in TAK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $695,878 | 43,411 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $850,845 | 45,942 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $730,578 | 46,862 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $712,367 | 48,659 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $438,461 | 28,361 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $205,369 | 13,811 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||